Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis (RECOVERY)

This study is currently recruiting participants.
Verified November 2012 by Asan Medical Center
Sponsor:
Collaborator:
Korea Institute of Medicine
Information provided by (Responsible Party):
Duk-Hyun Kang, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01161732
First received: July 12, 2010
Last updated: November 19, 2012
Last verified: November 2012

July 12, 2010
November 19, 2012
April 2010
April 2018   (final data collection date for primary outcome measure)
  • Cardiac mortality [ Time Frame: Entire follow-up ( a minimum of 4 years) ] [ Designated as safety issue: No ]
    defined as death from complications of myocardial infarction, heart failure, shock, complications of cardiac surgery or intervention, other cardiovascular diseases including sudden cardiac death
  • Operative mortality [ Time Frame: up to 30 days after surgery ] [ Designated as safety issue: Yes ]
    Operative mortality is defined as death within 30 days of surgery.
  • Cardiac mortality [ Time Frame: up to 4 years after enrollment ] [ Designated as safety issue: No ]
  • Operative mortality [ Time Frame: up to 30 days after surgery ] [ Designated as safety issue: Yes ]
    Operative mortality is defined as death within 30 days of surgery.
Complete list of historical versions of study NCT01161732 on ClinicalTrials.gov Archive Site
  • All-cause death [ Time Frame: Entire follow-up (a minimum of 4 years) ] [ Designated as safety issue: No ]
  • Repeat aortic valve surgery [ Time Frame: Entire follow-up (a minimum of 4 years) ] [ Designated as safety issue: Yes ]
  • Clinical thromboembolic events [ Time Frame: Entire follow-up (a minimum of 4 years) ] [ Designated as safety issue: Yes ]
    Diagnosis of thromboembolic events is based on clinical symptoms, signs and imaging studies.
  • Hospitalization due to congestive heart failure [ Time Frame: Entire follow-up (a minimum of 4 years) ] [ Designated as safety issue: No ]
    A hospitalization due to congestive heart failure is defined as an unplanned, urgent admission for the management of congestive heart failure.
  • All-cause death [ Time Frame: up to 4 years after enrollment ] [ Designated as safety issue: No ]
  • Repeat aortic valve surgery [ Time Frame: up to 4 years after enrollment ] [ Designated as safety issue: Yes ]
  • Clinical thromboembolic events [ Time Frame: up to 4 years after enrollment ] [ Designated as safety issue: Yes ]
    Diagnosis of thromboembolic events is based on clinical symptoms, signs and imaging studies.
  • Hospitalization due to congestive heart failure [ Time Frame: up to 4 years after enrollment ] [ Designated as safety issue: Yes ]
    A hospitalization due to congestive heart failure is defined as an unplanned, urgent admission for the management of congestive heart failure.
Not Provided
Not Provided
 
Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis
Randomized Comparison of Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis

The optimal timing of surgical intervention remains controversial in asymptomatic patients with very severe aortic stenosis. The investigators therefore try to compare long-term clinical outcomes of early surgery with those of conventional treatment strategy in a prospective randomized trial.

Management of asymptomatic patients with severe aortic stenosis (AS) remains controversial, and the combined risks of aortic valve surgery and late complications of aortic valve prosthesis need to be balanced against the possibility of preventing sudden death and lowering cardiac mortality. Considering that sudden cardiac death occurs at a rate of approximately 1% per year and that the average postoperative mortality of isolated AV replacement is 3.0-4.0%, the 2007 European Society of Cardiology guidelines do not recommend aortic valve surgery for asymptomatic patients with severe AS and the 2006 American College of Cardiology/American Heart Association guidelines recommend surgery as a class IIb indication only in patients with extremely severe AS and who are at low operative risk. Clinical outcomes vary widely according to the severity of stenosis in asymptomatic AS, and asymptomatic patients with very severe AS are often referred for aortic valve replacement in clinical practice despite the lack of data supporting early surgery. Rosenhek et al recently reported a worse prognosis with a higher event rate and a risk of rapid deterioration in very severe AS, and the investigators also recently reported that compared with the conventional treatment strategy, early surgery in patients with very severe AS is associated with an improved long-term survival in a prospective, observational study. However, there have been no prospective,randomized studies comparing early surgery with a watchful waiting strategy in very severe AS. We sought to compare long-term clinical outcomes of early surgery with those of conventional management based on current guidelines.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Aortic Stenosis
Procedure: Early surgery
Early surgery is performed within 2 months of randomization.
Other Name: Early aortic valve replacement surgery
  • No Intervention: Conventional treatment
    In the conventional treatment group, indications for aortic valve replacement surgery are development of symptoms, reduced left ventricular systolic function and an increase in aortic jet velocity > 0.5 m/sec during follow-up.
  • Active Comparator: Early Surgery
    Early surgery is performed within 2 months of randomization.
    Intervention: Procedure: Early surgery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
144
April 2018
April 2018   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • asymptomatic patients with very severe aortic stenosis who are potential candidates for early surgery. Very severe aortic stenosis are defined as a critical stenosis in the AV area ≤ 0.75 square centimeter fulfilling one of the following criteria; a peak aortic velocity ≥ 4.5 m/sec or a mean transaortic pressure gradient ≥ 50 mmHg on Doppler echocardiography.

Exclusion Criteria:

  • Exertional dyspnea
  • Angina
  • Syncope
  • Left ventricular ejection fraction < 50%
  • Significant aortic regurgitation
  • Significant mitral valve disease
  • Pregnancy
  • Age < 20 years or > 80 years
  • Coexisting malignancies
Both
20 Years to 80 Years
No
Contact: Duk-Hyun Kang, M.D. 82-2-3010-3166 dhkang@amc.seoul.kr
Contact: Dae-Hee Kim, M.D. 82-2-3010-3151 daehee74@amc.seoul.kr
Korea, Republic of
 
NCT01161732
2010-0065
Yes
Duk-Hyun Kang, Asan Medical Center
Asan Medical Center
Korea Institute of Medicine
Principal Investigator: Duk-Hyun Kang, M.D. Division of Cardiology, Asan Medical Center, University of Ulsan, College of Medicine
Asan Medical Center
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP